{"id":12509,"date":"2021-05-10T08:29:49","date_gmt":"2021-05-10T07:29:49","guid":{"rendered":"https:\/\/ppr-antibioresistance.inserm.fr\/?p=11065"},"modified":"2023-06-06T13:39:12","modified_gmt":"2023-06-06T12:39:12","slug":"resultats-de-laap-antibioresistance-comprendre-innover-agir-11-projets-retenus-pour-la-1e-action-du-ppr-antibioresistance","status":"publish","type":"post","link":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/resultats-de-laap-antibioresistance-comprendre-innover-agir-11-projets-retenus-pour-la-1e-action-du-ppr-antibioresistance\/","title":{"rendered":"R\u00e9sultats de l\u2019AAP \u00ab Antibior\u00e9sistance : comprendre, innover, agir \u00bb : 11 projets retenus pour la 1e action du PPR Antibior\u00e9sistance"},"content":{"rendered":"\n<p>Le 5 ao\u00fbt 2020, \u00e9tait lanc\u00e9 l\u2019appel \u00e0 projets (AAP) \u00ab Antibior\u00e9sistance : comprendre, innover, agir \u00bb par l\u2019Agence nationale de la recherche (ANR), auquel 25 M\u20ac ont \u00e9t\u00e9 d\u00e9di\u00e9s, et qui constituait la premi\u00e8re action du PPR Antibior\u00e9sistance. <\/p>\n\n\n\n<p>Onze projets viennent d\u2019\u00eatre retenus. <\/p>\n\n\n\n<p>En France, la multir\u00e9sistance aux antibiotiques est un probl\u00e8me de sant\u00e9 publique majeur. Afin de le contrer, le Gouvernement par l\u2019entremise du Secr\u00e9tariat g\u00e9n\u00e9ral \u00e0 l\u2019investissement (SGPI) a mis en place un Programme prioritaire de recherche (PPR) Antibior\u00e9sistance coordonn\u00e9 par l\u2019Inserm, dot\u00e9 de 40 M\u20ac sur 10 ans.<\/p>\n\n\n\n<p>Ces projets de recherche, se devaient d\u2019\u00eatre tr\u00e8s ambitieux, structurants, de longue dur\u00e9e (3 \u00e0 6 ans), de favoriser l\u2019interdisciplinarit\u00e9 et faire \u00e9merger une synergie sur la base d\u2019un continuum allant de la recherche fondamentale aux applications cliniques, v\u00e9t\u00e9rinaires et environnementales, en sciences humaines et sociales et en politique publique.<\/p>\n\n\n\n<p>Ce document a \u00e9t\u00e9 r\u00e9alis\u00e9 par la direction du PPR Antibior\u00e9sistance, en coordination avec le D\u00e9partement de l&#8217;Information Scientifique et de la Communication (DISC) de l\u2019Inserm et la soci\u00e9t\u00e9 prestataire MLcom.<br><br>Chaque projet porte sur un ou plusieurs des 4 challenges d\u00e9finis ci-dessous. L\u2019objectif visant \u00e0 stimuler et \u00e0 accompagner l\u2019\u00e9mergence d\u2019innovations diagnostiques, pr\u00e9ventives et th\u00e9rapeutiques est ainsi atteint.<br><br><strong>Challenge 1<\/strong> : Dynamiques et contr\u00f4le de l\u2019\u00e9mergence, de la transmission<br>et de la diss\u00e9mination de l\u2019antibior\u00e9sistance<br><strong>Challenge 2<\/strong> : Optimisation de l\u2019usage des antibiotiques en m\u00e9decines<br>humaine et v\u00e9t\u00e9rinaire<br><strong>Challenge 3<\/strong> : D\u00e9terminants individuels, ethnologiques et sociologiques,<br>\u00e9conomiques, politiques et culturels de l\u2019antibior\u00e9sistance<br><strong>Challenge 4<\/strong> : Innovation th\u00e9rapeutique<\/p>\n\n\n\n<p><strong>Projets retenus<\/strong><br>11 projets ont \u00e9t\u00e9 retenus sur environ 70 projets soumis (soit pr\u00e8s de 16 % de taux de succ\u00e8s) et ont re\u00e7u une dotation comprise entre 1 et 3 M\u20ac.<\/p>\n\n\n\n<p>Consultez <a href=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/05\/Resultats_AAP_PPRAntibioComprendreInnoverAgirv3.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">sur ce lien<\/a> la liste des projets retenus.<\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Le 5 ao\u00fbt 2020, \u00e9tait lanc\u00e9 l\u2019appel \u00e0 projets (AAP) \u00ab Antibior\u00e9sistance : comprendre, innover, agir \u00bb par l\u2019Agence nationale de la recherche (ANR), auquel 25 M\u20ac ont \u00e9t\u00e9 d\u00e9di\u00e9s, et qui constituait la premi\u00e8re action du PPR Antibior\u00e9sistance. Onze projets viennent d\u2019\u00eatre retenus. En France, la multir\u00e9sistance aux antibiotiques est un probl\u00e8me de sant\u00e9 [&hellip;]<\/p>\n","protected":false},"author":139,"featured_media":12353,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[31,41],"tags":[],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>R\u00e9sultats de l\u2019AAP \u00ab Antibior\u00e9sistance : comprendre, innover, agir \u00bb : 11 projets retenus pour la 1e action du PPR Antibior\u00e9sistance - Interface nationale ANTIBIOR\u00c9SISTANCE<\/title>\n<meta name=\"description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l&#039;Antibior\u00e9sistance en France et \u00e0 l&#039;international.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/resultats-de-laap-antibioresistance-comprendre-innover-agir-11-projets-retenus-pour-la-1e-action-du-ppr-antibioresistance\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"R\u00e9sultats de l\u2019AAP \u00ab Antibior\u00e9sistance : comprendre, innover, agir \u00bb : 11 projets retenus pour la 1e action du PPR Antibior\u00e9sistance - Interface nationale ANTIBIOR\u00c9SISTANCE\" \/>\n<meta property=\"og:description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l&#039;Antibior\u00e9sistance en France et \u00e0 l&#039;international.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/resultats-de-laap-antibioresistance-comprendre-innover-agir-11-projets-retenus-pour-la-1e-action-du-ppr-antibioresistance\/\" \/>\n<meta property=\"og:site_name\" content=\"Interface nationale ANTIBIOR\u00c9SISTANCE\" \/>\n<meta property=\"article:published_time\" content=\"2021-05-10T07:29:49+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-06-06T12:39:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/05\/Lauriers.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"413\" \/>\n\t<meta property=\"og:image:height\" content=\"322\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"\u00c9milie Noguez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"\u00c9milie Noguez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/resultats-de-laap-antibioresistance-comprendre-innover-agir-11-projets-retenus-pour-la-1e-action-du-ppr-antibioresistance\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/resultats-de-laap-antibioresistance-comprendre-innover-agir-11-projets-retenus-pour-la-1e-action-du-ppr-antibioresistance\/\"},\"author\":{\"name\":\"\u00c9milie Noguez\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3\"},\"headline\":\"R\u00e9sultats de l\u2019AAP \u00ab Antibior\u00e9sistance : comprendre, innover, agir \u00bb : 11 projets retenus pour la 1e action du PPR Antibior\u00e9sistance\",\"datePublished\":\"2021-05-10T07:29:49+00:00\",\"dateModified\":\"2023-06-06T12:39:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/resultats-de-laap-antibioresistance-comprendre-innover-agir-11-projets-retenus-pour-la-1e-action-du-ppr-antibioresistance\/\"},\"wordCount\":331,\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/resultats-de-laap-antibioresistance-comprendre-innover-agir-11-projets-retenus-pour-la-1e-action-du-ppr-antibioresistance\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/05\/Lauriers.jpg\",\"articleSection\":[\"Actualit\u00e9s\",\"Actualit\u00e9s PPR Antibior\u00e9sistance\"],\"inLanguage\":\"fr-FR\"},{\"@type\":[\"WebPage\",\"ItemPage\"],\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/resultats-de-laap-antibioresistance-comprendre-innover-agir-11-projets-retenus-pour-la-1e-action-du-ppr-antibioresistance\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/resultats-de-laap-antibioresistance-comprendre-innover-agir-11-projets-retenus-pour-la-1e-action-du-ppr-antibioresistance\/\",\"name\":\"R\u00e9sultats de l\u2019AAP \u00ab Antibior\u00e9sistance : comprendre, innover, agir \u00bb : 11 projets retenus pour la 1e action du PPR Antibior\u00e9sistance - Interface nationale ANTIBIOR\u00c9SISTANCE\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/resultats-de-laap-antibioresistance-comprendre-innover-agir-11-projets-retenus-pour-la-1e-action-du-ppr-antibioresistance\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/resultats-de-laap-antibioresistance-comprendre-innover-agir-11-projets-retenus-pour-la-1e-action-du-ppr-antibioresistance\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/05\/Lauriers.jpg\",\"datePublished\":\"2021-05-10T07:29:49+00:00\",\"dateModified\":\"2023-06-06T12:39:12+00:00\",\"description\":\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.\",\"breadcrumb\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/resultats-de-laap-antibioresistance-comprendre-innover-agir-11-projets-retenus-pour-la-1e-action-du-ppr-antibioresistance\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/resultats-de-laap-antibioresistance-comprendre-innover-agir-11-projets-retenus-pour-la-1e-action-du-ppr-antibioresistance\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/resultats-de-laap-antibioresistance-comprendre-innover-agir-11-projets-retenus-pour-la-1e-action-du-ppr-antibioresistance\/#primaryimage\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/05\/Lauriers.jpg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/05\/Lauriers.jpg\",\"width\":413,\"height\":322,\"caption\":\"Cr\u00e9dit : Pixabay\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/resultats-de-laap-antibioresistance-comprendre-innover-agir-11-projets-retenus-pour-la-1e-action-du-ppr-antibioresistance\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Infos pratiques &amp; communications\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Actualit\u00e9s\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"R\u00e9sultats de l\u2019AAP \u00ab Antibior\u00e9sistance : comprendre, innover, agir \u00bb : 11 projets retenus pour la 1e action du PPR Antibior\u00e9sistance\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\",\"name\":\"Interface nationale ANTIBIOR\u00c9SISTANCE\",\"description\":\"PPR Antibior\u00e9sistance - Inserm\",\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\",\"name\":\"Inserm\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"width\":1,\"height\":1,\"caption\":\"Inserm\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3\",\"name\":\"\u00c9milie Noguez\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"R\u00e9sultats de l\u2019AAP \u00ab Antibior\u00e9sistance : comprendre, innover, agir \u00bb : 11 projets retenus pour la 1e action du PPR Antibior\u00e9sistance - Interface nationale ANTIBIOR\u00c9SISTANCE","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/resultats-de-laap-antibioresistance-comprendre-innover-agir-11-projets-retenus-pour-la-1e-action-du-ppr-antibioresistance\/","og_locale":"fr_FR","og_type":"article","og_title":"R\u00e9sultats de l\u2019AAP \u00ab Antibior\u00e9sistance : comprendre, innover, agir \u00bb : 11 projets retenus pour la 1e action du PPR Antibior\u00e9sistance - Interface nationale ANTIBIOR\u00c9SISTANCE","og_description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","og_url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/resultats-de-laap-antibioresistance-comprendre-innover-agir-11-projets-retenus-pour-la-1e-action-du-ppr-antibioresistance\/","og_site_name":"Interface nationale ANTIBIOR\u00c9SISTANCE","article_published_time":"2021-05-10T07:29:49+00:00","article_modified_time":"2023-06-06T12:39:12+00:00","og_image":[{"width":413,"height":322,"url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/05\/Lauriers.jpg","type":"image\/jpeg"}],"author":"\u00c9milie Noguez","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"\u00c9milie Noguez","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/resultats-de-laap-antibioresistance-comprendre-innover-agir-11-projets-retenus-pour-la-1e-action-du-ppr-antibioresistance\/#article","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/resultats-de-laap-antibioresistance-comprendre-innover-agir-11-projets-retenus-pour-la-1e-action-du-ppr-antibioresistance\/"},"author":{"name":"\u00c9milie Noguez","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3"},"headline":"R\u00e9sultats de l\u2019AAP \u00ab Antibior\u00e9sistance : comprendre, innover, agir \u00bb : 11 projets retenus pour la 1e action du PPR Antibior\u00e9sistance","datePublished":"2021-05-10T07:29:49+00:00","dateModified":"2023-06-06T12:39:12+00:00","mainEntityOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/resultats-de-laap-antibioresistance-comprendre-innover-agir-11-projets-retenus-pour-la-1e-action-du-ppr-antibioresistance\/"},"wordCount":331,"publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/resultats-de-laap-antibioresistance-comprendre-innover-agir-11-projets-retenus-pour-la-1e-action-du-ppr-antibioresistance\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/05\/Lauriers.jpg","articleSection":["Actualit\u00e9s","Actualit\u00e9s PPR Antibior\u00e9sistance"],"inLanguage":"fr-FR"},{"@type":["WebPage","ItemPage"],"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/resultats-de-laap-antibioresistance-comprendre-innover-agir-11-projets-retenus-pour-la-1e-action-du-ppr-antibioresistance\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/resultats-de-laap-antibioresistance-comprendre-innover-agir-11-projets-retenus-pour-la-1e-action-du-ppr-antibioresistance\/","name":"R\u00e9sultats de l\u2019AAP \u00ab Antibior\u00e9sistance : comprendre, innover, agir \u00bb : 11 projets retenus pour la 1e action du PPR Antibior\u00e9sistance - Interface nationale ANTIBIOR\u00c9SISTANCE","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/resultats-de-laap-antibioresistance-comprendre-innover-agir-11-projets-retenus-pour-la-1e-action-du-ppr-antibioresistance\/#primaryimage"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/resultats-de-laap-antibioresistance-comprendre-innover-agir-11-projets-retenus-pour-la-1e-action-du-ppr-antibioresistance\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/05\/Lauriers.jpg","datePublished":"2021-05-10T07:29:49+00:00","dateModified":"2023-06-06T12:39:12+00:00","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","breadcrumb":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/resultats-de-laap-antibioresistance-comprendre-innover-agir-11-projets-retenus-pour-la-1e-action-du-ppr-antibioresistance\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/resultats-de-laap-antibioresistance-comprendre-innover-agir-11-projets-retenus-pour-la-1e-action-du-ppr-antibioresistance\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/resultats-de-laap-antibioresistance-comprendre-innover-agir-11-projets-retenus-pour-la-1e-action-du-ppr-antibioresistance\/#primaryimage","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/05\/Lauriers.jpg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/05\/Lauriers.jpg","width":413,"height":322,"caption":"Cr\u00e9dit : Pixabay"},{"@type":"BreadcrumbList","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/resultats-de-laap-antibioresistance-comprendre-innover-agir-11-projets-retenus-pour-la-1e-action-du-ppr-antibioresistance\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/"},{"@type":"ListItem","position":2,"name":"Infos pratiques &amp; communications","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/"},{"@type":"ListItem","position":3,"name":"Actualit\u00e9s","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/"},{"@type":"ListItem","position":4,"name":"R\u00e9sultats de l\u2019AAP \u00ab Antibior\u00e9sistance : comprendre, innover, agir \u00bb : 11 projets retenus pour la 1e action du PPR Antibior\u00e9sistance"}]},{"@type":"WebSite","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/","name":"Interface nationale ANTIBIOR\u00c9SISTANCE","description":"PPR Antibior\u00e9sistance - Inserm","publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization","name":"Inserm","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","width":1,"height":1,"caption":"Inserm"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3","name":"\u00c9milie Noguez"}]}},"publishpress_future_action":{"enabled":false,"date":"2026-04-19 02:16:44","action":"change-status","newStatus":"private","terms":[],"taxonomy":"category"},"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/12509"}],"collection":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/users\/139"}],"replies":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/comments?post=12509"}],"version-history":[{"count":2,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/12509\/revisions"}],"predecessor-version":[{"id":12879,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/12509\/revisions\/12879"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/media\/12353"}],"wp:attachment":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/media?parent=12509"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/categories?post=12509"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/tags?post=12509"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}